Literature DB >> 35282533

An Uncommon Presentation of Cryptococcal Meningoencephalitis.

Isabel Freitas1, Tatiana Salazar2, Pedro Rodrigues3, Maria Vilela1, Augusto Duarte1.   

Abstract

Cryptococcal meningoencephalitis (CM) remains a common cause of central nervous system infections. Patients usually present with headache, fever, malaise, and altered mental status over several weeks. Signs are often absent, but they may include meningism, papilledema, cranial nerve palsies, and depressed level of consciousness. Individuals with CM can occasionally present with small vessel vasculitis causing cerebral lesions. The literature regarding patterns of cerebrovascular injury in CM is scarce. We describe a case of CM in which an unusual presentation was observed: transient focal neurological symptoms initially with absence of fever that led to a misleading primary diagnosis of transient ischemic attack. Since neurological symptoms may be a manifestation of a cryptococcal infection, it is necessary to have a high degree of suspicion for this pathology in the presence of focal neurological deficits, even in patients with vascular risk factors, requiring a thorough etiological investigation.
Copyright © 2022, Freitas et al.

Entities:  

Keywords:  cryptococcal meningoencephalitis; cryptococcus neoformans; hiv; meningoencephalitis; transient ischemic attack

Year:  2022        PMID: 35282533      PMCID: PMC8906445          DOI: 10.7759/cureus.21984

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  11 in total

1.  HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era.

Authors:  Lucy Garvey; Alan Winston; John Walsh; Frank Post; Kholoud Porter; Brian Gazzard; Martin Fisher; Clifford Leen; Deenan Pillay; Teresa Hill; Margaret Johnson; Richard Gilson; Jane Anderson; Philippa Easterbrook; Loveleen Bansi; Chloe Orkin; Jonathan Ainsworth; Andrew N Phillips; Caroline A Sabin
Journal:  Eur J Neurol       Date:  2010-12-15       Impact factor: 6.089

2.  The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitis.

Authors:  Spinello Antinori; Anna Radice; Laura Galimberti; Carlo Magni; Marco Fasan; Carlo Parravicini
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

3.  Torulomas (cryptococcal granulomata) of the central nervous system.

Authors:  R C Selby; N M Lopes
Journal:  J Neurosurg       Date:  1973-01       Impact factor: 5.115

4.  Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.

Authors:  Radha Rajasingham; Rachel M Smith; Benjamin J Park; Joseph N Jarvis; Nelesh P Govender; Tom M Chiller; David W Denning; Angela Loyse; David R Boulware
Journal:  Lancet Infect Dis       Date:  2017-05-05       Impact factor: 25.071

5.  Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions.

Authors:  P Mwaba; J Mwansa; C Chintu; J Pobee; M Scarborough; S Portsmouth; A Zumla
Journal:  Postgrad Med J       Date:  2001-12       Impact factor: 2.401

6.  Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome.

Authors:  M L Cameron; J A Bartlett; H A Gallis; H A Waskin
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

7.  Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe.

Authors:  R S Heyderman; I T Gangaidzo; J G Hakim; J Mielke; A Taziwa; P Musvaire; V J Robertson; P R Mason
Journal:  Clin Infect Dis       Date:  1998-02       Impact factor: 9.079

8.  AIDS-related CNS cryptococcosis: radiologic-pathologic correlation.

Authors:  V P Mathews; P L Alo; J D Glass; A J Kumar; J C McArthur
Journal:  AJNR Am J Neuroradiol       Date:  1992 Sep-Oct       Impact factor: 3.825

Review 9.  Treatment strategies for cryptococcal infection: challenges, advances and future outlook.

Authors:  Kali R Iyer; Nicole M Revie; Ci Fu; Nicole Robbins; Leah E Cowen
Journal:  Nat Rev Microbiol       Date:  2021-02-08       Impact factor: 60.633

10.  Treatment and outcomes among patients with Cryptococcus gattii infections in the United States Pacific Northwest.

Authors:  Rachel M Smith; Adamma Mba-Jonas; Mathieu Tourdjman; Trisha Schimek; Emilio DeBess; Nicola Marsden-Haug; Julie R Harris
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.